Molecular motors play important roles in force generation, migration and intracellular trafficking.
Introduction
Molecular motors convert chemical energy into mechanical work to achieve active cellular processes.
The physical properties of molecular motors have been extensively studied in vitro by single molecular approaches [1] [2] [3] . In cells, assemblies of molecular motors and collective active processes generate random fluctuating forces in the cytoplasm, which have recently been measured using force spectrum microscopy 4 . However, the individual contribution of a given type of molecular motor to cell mechanics is still unexplored. Kinesins form a superfamily of molecular motors that interact with microtubules and regulate key cell functions including mitosis, cell migration and organelle transport [5] [6] [7] [8] [9] . We focus here on the role of the KIF20A kinesin (also called MKLP2 for mitotic kinesin-like protein 2 or Rabkinesin-6) in the mechanics of bladder cancer cells. KIF20A is a microtubule plus-end directed motor of the kinesin-6 family 10 . KIF20A was initially shown to bind the small G protein RAB6 and to regulate retrograde transport from the Golgi apparatus to the endoplasmic reticulum (ER) during interphase 11 . In mitosis, KIF20A localizes to the central spindle, and its phosphorylation is required for cytokinesis 12 . A recent study shows that KIF20A and myosin II interact at Golgi hotspots to regulate the intracellular trafficking of RAB6-positive vesicles during interphase 13 . KIF20A is involved in the fission of transport intermediates from the Golgi apparatus and serves to anchor RAB6 on Golgi and trans-Golgi network (TGN) membranes near microtubule nucleating sites 11, 13, 14 . The regulation of myosin II might also be affected by KIF20A dynamics and thereby affect force generation and intracellular microrheological properties [15] [16] [17] . It was recently reported that, during cortical neurogenesis, knockout of KIF20A causes the loss of neural progenitor cells and neurons due to early cell cycle exit and neuronal differentiation 18 .
KIF20A was previously reported to be highly upregulated in many cancer cell types such as pancreatic cancer, melanoma, bladder cancer, liver cancer and breast cancer [19] [20] [21] [22] [23] [24] [25] . Overexpression of KIF20A is associated with increased proliferation and tumor progression, poor prognosis and increased drug resistance in many cancers 26, 27 . In contrast, downregulation of KIF20A reduces cell proliferation in pancreatic cancer and glioma cells due to cytokinesis failure, appearance of binucleated cells, and apoptosis 26, 28 . However it has also been proposed that KIF20A could play antagonistic roles by both activating and inhibiting tumor progression 19 . Peptides derived from KIF20A have been used to activate the immune system to kill cancer cells, which endogenously express the KIF20A antigen 29 . Hence, KIF20A has become an immunotherapeutic target for several cancers, such as pancreatic or breast cancers [29] [30] [31] .
Cell stiffness is often altered in pathological situations including fibrosis and cancer [32] [33] [34] [35] [36] . In most cancers, isolated cancer cells have been shown to be softer than their healthy counterparts 36, 37 .
Cancer cell softening is thought to be a key event during the metastatic process because more deformable cells should migrate more efficiently through confined environments to form metastases at a distant site from the primary tumor. Since actomyosin contractility has been shown to be crucial for maintaining cell stiffness and for force generation 38, 39 , a large body of research has been dedicated to study the role of actomyosin in cell mechanics [40] [41] [42] . In contrast, the role of the microtubule cytoskeleton and its associated motors in cell stiffness has been much less studied. In In this study, we investigate the mechanical role of KIF20A in bladder cancer cells using a combination of active microrheological intracellular measurements by optical tweezers and atomic force microscopy (AFM) indentation experiments. We focus here on the role of KIF20A in regulating intracellular and cortical mechanics and correlate the mechanical effects of KIF20A with its effects on cell migration. Our results suggest that the interaction of KIF20A with myosin II differently regulates intracellular and cortical mechanics. The role of KIF20A in cell mechanics and cell migration points to KIF20A as a potential therapeutic target for bladder cancer.
Results

Bladder cancer cells are softer than normal urothelial cells
We first compared the viscoelastic properties of primary normal human urothelial (NHU) cells and two bladder cancer cell lines, grade II RT112 cells and grade III KU19-19 (KU) cells using intracellular active microrheology and AFM indentation experiments ( Fig. 1 ). Cells were plated on crossbow shaped adhesive micropatterns to normalize their shape and intracellular organization. Internalized 2 µm diameter beads were displaced in an oscillatory fashion using optical tweezers-based rheology to measure the intracellular shear modulus ( Fig. 1A , see Methods). We found that the intracellular shear modulus was almost twice higher in normal NHU cells than in bladder cancer cells and was significantly reduced in grade III cells compared to grade II cells ( Fig. 1A) . Intracellular relaxation experiments of beads trapped by optical tweezers (Fig.1B ) allowed us to measure two phenomenological parameters, the rigidity index and the bead step amplitude, and to extract the complex shear modulus using a model based on power law rheology (see Methods). These measurements confirmed that lower grade (RT112) cells are softer than higher grade (T24) cells 36, 37 ( Fig. 1B ). AFM indentation experiments showed that stiffness is also lower in grade III cells (Fig. 1C ).
Note that the stiffness measured by AFM indentation experiments was larger by two orders of magnitude than the intracellular stiffness measured either by oscillation or relaxation experiments, suggesting that AFM measurements are dominated by cortical stiffness. Stiffness maps obtained on micropatterned cells show a strong spatial dispersion of stiffness values ( Fig. 1D) with higher values in the perinuclear region in both RT112 and KU cells, as observed using intracellular rheology 43 .
Despite the spatial variability of the elasticity measurements, the perinuclear region appears to be softer in grade III cells than in grade II cells ( Fig. 1.D) , consistent with the spatially averaged data (Fig. 1C ).
Inhibiting KIF20A softens the cell cytoplasm
Out-of-equilibrium active cellular processes impact strongly on cell rheology 44 . While acto-myosin contractility is well-known to play a major role in the mechanical properties of cells and in force generation, the role of the microtubule-associated kinesin motors in cell mechanics is much less studied. Because the expression levels of several molecular motors including KIF20A have been shown to be deregulated in bladder cancer 19 , we asked whether the kinesin KIF20A could participate in bladder cancer cell mechanics. We inhibited KIF20A by treating RT112 and KU bladder cancer 
KIF20A regulates cortical stiffness and cell motility on both soft and stiff substrates
To correlate intracellular rheology with the mechanical properties of the cell cortex, we measured cortical stiffness in RT112 and KU cells by AFM indentation experiments. Surprisingly, while grade II RT112 cells became softer when KIF20A was inhibited, grade III KU cells became stiffer ( Fig. 3 A, B) .
The effects of KIF20A on bladder cancer cell rheology suggest that KIF20A impacts cellular functions that depend on cell mechanics such as cell migration. We studied individual 2D cell motility by plating RT112 and KU bladder cancer cells on soft (G=500 Pa) polyacrylamide hydrogels or on stiff (glass) substrates ( Fig. 4 ). On both substrates, the higher-grade KU cells moved about twice as fast as the lower grade RT122 cells ( Fig. 4 A, B and supplementary movies 1 and 2). When KIF20A was inhibited, the motility of RT112 and KU cells decreased. The speed of KU cells decreased about 3-fold and 4-fold on stiff and soft substrates respectively. In contrast, KIF20A inhibition had less effect on RT112 cell motility with only a 1.5-fold and 1.1-fold decrease in cell speed on stiff and soft substrates respectively (Fig. 4A , B and supplementary movies 3 and 4).
Inhibiting KIF20A affects the subcellular localization of cortical actin and myosin II
We have shown so far that the effects of KIF20A inhibition are different in grade II RT112 cells and in grade III KU cells. First, KIF20A inhibition decreases cortical stiffness in RT112 cells, whereas it increases cortical stiffness in KU cells ( Fig. 3 ). Second, KIF20A has stronger effects on single cell motility in KU cells than in RT112 cells, especially on soft substrates ( Fig. 4 ). To explain these differences, we have first compared the expression levels and localization of KIF20A in both cell lines.
RT112 cells express higher levels of KIF20A than KU cells ( Fig. 5A ). Since RT112 and KU have different cell cycle durations, we also measured the KIF20A expression levels in synchronized cells and found a similar trend as in non-synchronized cells, but with higher amounts of KIF20A ( Fig. 5A ).
Because KIF20A interacts with myosin II 13 , inhibition of KIF20A may have an effect on myosin II localization and/or cell contractility and hence cortical stiffness and cell motility. We first checked that KIF20A inhibition does not alter the expression levels of KIF20A and myosin II ( Fig. 5B ) and that the previously reported KIF20A/myosin II interaction also occurs in bladder cancer cells (Fig. 5C ). The interaction between KIF20A and myosin II was comparable in RT112 and KU cells but was specifically reduced in KU cells when KIF20A was inhibited ( Fig. 5C ). We then asked whether KIF20A inhibition could affect KIF20A localization and the distribution of cytoskeletal fibers. While KIF20A inhibition did not affect the colocalization of KIF20A with microtubules and myosin in the perinuclear region ( Fig. 5D and S1), the distribution of actin and myosin II was clearly affected in KU cells, but not in RT112 cells, with actin and myosin accumulating at the cell periphery specifically in KU cells ( Fig.   5D and S1). Such enrichment in peripheral contractile acto-myosin upon KIF20A inhibition in KU cells could be responsible for the increase in cortical stiffness and the effects on migration observed specifically in this cell line.
Discussion
We report here that the KIF20A kinesin motor plays a major role in bladder cancer cell mechanics.
We found that a grade II (RT112) and a grade III (KU) bladder cancer lines are softer than normal urinary human (NHU) cells at the intracellular scale ( Figure 1A ), consistent with previously published results 36, 37 . When KIF20A was inhibited, intracellular rigidity decreased in both cell lines ( Fig. 2) .
While a cortical softening concomitant with intracellular softening occurred in RT112 cells, KU cells exhibited a stiffer cortex upon KIF20A inhibition ( Fig. 3 ). To our knowledge, this is the first observation of an effect of a microtubule motor on cortical mechanics.
The mechanical effects of KIF20A are mediated by its interaction with myosin II and subsequent regulation of the subcellular localization of actin and myosin II. The KIF20A/myosin II interaction was originally described to occur through Rab6 at the Golgi apparatus 13 . We have focused here on the effects of KIF20A inhibition at the cell cortex, but it is likely that inhibition of KIF20A also perturbs post-Golgi trafficking and more generally intracellular transport. We propose that two pools of myosin II interact with KIF20A, a first pool localized at the Golgi apparatus and a second pool localized at the cell cortex ( Fig. S1, S2 ). Inhibition of KIF20A may affect the Golgi pool in both RT112 and KU cells and reduce intracellular stiffness by softening internal membranes 43 such as Golgi membranes where KIF20A and myosin interact.
Additional effects of KIF20A inhibition on intracellular transport or microtubule dynamics, especially those of Golgi-nucleated microtubules, may also contribute to intracellular softening. In KU cells which display lower basal levels of KIF20A, the KIF20A/myosin II interaction is decreased when KIF20A is inhibited, which may release myosin II from Golgi membranes and allow enrichment of acto-myosin at the cortex. Such an increase in cortical acto-myosin density may lead to the stiffening of the cortex and to the reduced cell motility observed specifically in KU cells ( Fig. 4 ). Because RT112 cells have a higher basal level of KIF20A and inhibition of KIF20A does not impact its interaction with myosin II in these cells ( Fig. 5 and see discussion below), KIF20A inhibition could perturb the cortical pool of myosin II to a lesser extent and have a lower effect on cell motility in RT112 cells. Traction force measurements could help clarify the effects of KIF20A inhibition on cell-substrate adhesion and on cell motility 41, 46, 47 .
The different effects of KIF20A inhibition in RT112 and KU cells can likely be explained by the difference in KIF20A expression levels ( Fig. 5A ) and by the different strength of the previously reported KIF20A/myosin II interaction 13 (Fig. 5B-C ). We found that inhibiting KIF20A did not affect the levels of KIF20A or myosin II in either cell line ( Fig. 5B ) but strongly reduced the KIF20A/myosin II interaction in KU cells but not in RT112 cells (Fig. 5C ). In parallel with the reduced KIF20A/myosin II inhibition, actin and myosin reorganized at the cortex of KU cells ( Similarly, KIF20A was reported to participate in actin rearrangement and protrusion formation in pancreatic cancer cells 48 . In contrast no significant change in cortical acto-myosin organization was observed in RT112 cells, which correlates with the lower effects of KIF20A inhibition on RT112 cell motility.
Because microtubules play a central role in cell division, they have been early targets of cancer drug treatments. For instance, taxol (Paclitaxel) blocks mitosis by stabilizing microtubules and is a widely used chemotherapy drug. Similarly, microtubule-associated molecular motors are potential targets for cancer therapy 49 . Kinesins and dynein play a crucial role in many cellular functions such as mitosis and cell proliferation and, not surprisingly, the expression levels of kinesins are often modified during tumor progression. Here we have used the specific KIF20A inhibitor paprotrain to study the effects of KIF20A inhibition on mechanical phenotypes in RT112 and KU bladder cancer cells. Our results point to KIF20A as a potential target for bladder cancer therapy. KIF20A inhibition had stronger effects on single cell motility in KU cells than in RT112 cells (Fig. 4 ). The velocity decreased by a factor greater than two in the case of KU cells on stiff or soft substrates ( Fig. 4B ).
Thus, KIF20A is involved in two hallmarks of malignant transformation, hyper-proliferation and, as we show here through its role in cell mechanics, increased cell motility. We can thus speculate that a KIF20A inhibitor could be of considerable therapeutic interest as it would not only target cancer cell proliferation but also motility and probably invasion.
Material and Methods
Cell culture and reagents RT112 and KU19-19 (KU) cells were grown in RPMI medium supplemented with 10% (vol/vol) FBS and 1% Penicillin/Streptomycin at 37 °C with 5% (vol/vol) CO 2 
Adhesive micropatterns
Crossbow-shaped micropatterns were printed on PEG-coated glass coverslips by deep UV photolithography, and then coated with 50 μ g/mL fibronectin and 20 μ g/mL Alexa 546-fibrinogen-red (Sigma). Cells were seeded on freshly prepared protein-coated micropatterns and allowed to spread for at least 2-3 hrs before experiment started 50 . Non-adherent cells were washed off by rinsing with culture medium.
Optical tweezers-based intracellular microrheology, image acquisition, and data processing
The setup combining optical tweezers and fast confocal microscopy was described in detail previously 43 
Intracellular relaxation experiments
We assume that the creep function ሺ ሻ behaves as a power law with an exponent α and a prefactor A, ሺ ሻ ൌ ࢻ as described in 43 (see methods). The bead position ‫ݔ‬ ሺ ‫ݐ‬ ሻ was fitted using:
We use the first four terms of Eq.1 to fit the first ten seconds of the relaxation of the bead position .
The prefactor A and the exponent α are the only two fit parameters in Eq. 1. Because bead tracking was noisier at longer timescales due to intracellular dynamics, the data was fitted using the following weights: 0.9, 0.09 and 0.01 for 0<t<2s, 2<t<5s and 5<t<10s respectively. The complex shear modulus G = G' + iG'' was deduced from A and α using:
As in 43 , we also used a phenomenological index to quantify intracellular rigidity which we called the 'rigidity index' (RI) and defined as:
. RI varies between 0 and 1. The bead step amplitude X b corresponds to the initial displacement of the bead following the step displacement of the stage (X s =0.5 µm > X b ).
Intracellular oscillations experiments
The bead is initially trapped at the center of the optical tweezers at time t =0 s. is 0 for a purely elastic material and π/2 for a purely viscous material. The complex shear modulus is given by
is the storage modulus and
is the loss modulus.
The frequency was fixed to ω=1 Hz and the amplitude of the stage displacement was 
Co-Immunoprecipitation
The previously reported interaction between myosin II and KIF20A was tested by coimmunoprecipitation in bladder cancer cells. RT112 and KU cells were treated with 2 mg/ml nocodazole for 16 hrs. Cells were washed and supplemented with fresh media to recover. Cells were either treated with DMSO or with 50μM paprotrain for 1 hr, washed twice in PBS, and incubated on ice for 60 min in a lysis buffer (25mM Tris pH 7.5, 50 mM NaCl, 0.1% NP40, with freshly added protease and phosphatase inhibitor cocktails (Sigma). Cells were clarified by centrifuging at 10,000g for 10 minutes. 500 µg of cell lysates were processed for co-immunoprecipitation using 5 µg of 
Figure legends
